BIOMAT Database Logo BIOMAT Database Logo

Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors. 2012

Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Department of Chemistry, Fudan University, Shanghai 200433, PR China.

A series of N-phenylarylformamide derivatives (PAFAs) with anti-wild-type HIV-1 activity (EC(50) values) ranging from 0.3 nM to 5.1 nM and therapeutic index (TI) ranging from 10 616 to 271 000 were identified as novel non-nucleoside reverse transcriptase inhibitors. Among them, compound 13g (EC(50) = 0.30 nM, TI = 184 578), 13l (EC(50) = 0.37 nM, TI = 212 819), 13m (EC(50) = 0.32 nM, TI = 260 617) and 13r (EC(50) = 0.27 nM, TI = 271 000) displayed the highest activity against this type virus nearly as potent as lead compound GW678248. Moreover, all of them were also active to inhibit the double mutant strain A(17) (K103N + Y181C) with EC(50) values of 0.29 μM, 0.14 μM, 0.10 μM and 0.27 μM, respectively. In particular, compound 13m, which showed broad-spectrum anti-HIV activity, was also effective to inhibit the HIV-2 ROD replication within 4.37 μM concentration.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005559 Formamides A group of amides with the general formula of R-CONH2.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics

Related Publications

Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
December 2006, ChemMedChem,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
December 2006, ChemMedChem,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors.
January 2020, Turkish journal of chemistry,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
February 2008, Bioorganic & medicinal chemistry letters,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Molecular Docking Studies and Synthesis of Amino-oxy-diarylquinoline Derivatives as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.
December 2019, Drug research,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.
February 2005, Bioorganic & medicinal chemistry,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
January 2019, Current computer-aided drug design,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.
December 2002, Proteins,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
April 2012, Journal of molecular modeling,
Xiao-Dong Ma, and Qiu-Qin He, and Xuan Zhang, and Shi-Qiong Yang, and Liu-Meng Yang, and Shuang-Xi Gu, and Yong-Tang Zheng, and Fen-Er Chen, and Hui-Fang Dai
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
June 2012, ACS medicinal chemistry letters,
Copied contents to your clipboard!